Sun Pharma acquires Disperzyme and Phlogam manufacturers in India

Sun Pharma acquires Disperzyme and Phlogam manufacturers in India

by admin- Monday, January 30th, 2023 03:29:12 PM

Sun Pharmaceutical Industries has received 3 manufacturers viz. Disperzyme (Trypsin BP 96 mg, Bromelain 180 mg & Rutoside Trihydrate 2 hundred mg), Disperzyme-CD (Trypsin BP 48 mg, Bromelain ninety mg & Rutoside Trihydrate a hundred mg) and Phlogam (Trypsin BP 48 mg, Bromelain 90 mg & Rutoside Trihydrate 100 mg) from Aksigen Hospital Care (“Aksigen”), a Mumbai based totally studies driven healthcare entity with extra than a long time of experience inside the healthcare subject. All the manufacturers are accepted with the aid of the Drugs Controller General of India (“DCGI”) for submit-operative infection in patients present process minor surgery and dental methods.

News Updates